Protagenic Therapeutics, Inc.\new (PTIX): key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$0

Net Income/Loss (FY2025)

$1.4M

Total Assets (FY2025)

$3.7M

Total Equity (FY2025)

$2.6M

Cash Flows from Operating Activities (FY2025)

-$2.8M

Source: Protagenic Therapeutics, Inc.\new 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.